 |
市場調查報告書
商品編碼
1567227
注射用抑菌水市場：按容器類型、按應用、按最終用戶、按地區Bacteriostatic Water for Injection Market, By Container Type, By Application, By End User, By Geography |
||||||
預計2024年全球抑菌注射水市場規模為12.2億美元，預計2031年將達20.9億美元，2024年至2031年複合年成長率為8%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 12.2億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024年至2031年 |
| 預測 2024-2031 年複合年成長率： | 8.00% | 2031年價值預測 | 20.9億美元 |
抑菌注射用水是指在配製和使用過程中含有適當濃度的防腐劑以抑制接種微生物生長的無菌水。抑菌水用於沖調粉狀藥物和其他製劑，以消除注射和輸注過程中微生物污染的風險。在醫院和診所，它被用來配製抗生素、抗真菌藥物和其他注射藥物等藥物。全球慢性病和感染疾病的流行以及醫療保健支出的增加可能會推動預測期內對注射用抑菌水的需求。
市場動態：
癌症和心血管疾病等慢性疾病的盛行率不斷上升，可能會增加對各種治療注射劑的需求，這將推動預測期內全球抑菌注射水市場的成長。醫療保健支出的增加，尤其是在新興國家，以及醫療設施的改善，可以成為市場成長的動力。然而，生理食鹽水等替代品的可用性可能會阻礙市場成長。同時，正在研究開發更有效的防腐劑和與更廣泛的注射藥物相容的配方，這可能在不久的將來為製造商帶來利潤豐厚的機會。
本研究的主要特點
該報告對全球抑菌注射用水市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
本研究涵蓋的主要企業包括 B. Braun Medical Inc、HOSPIRA、Medline、Baxter、ICU Medical 和 Hyperdrug。
本報告中的見解將幫助負責人和公司經營團隊就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球注射用抑菌水市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球注射用抑菌水市場的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章 市場動態、法規與趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章全球注射抑菌水市場－冠狀病毒（COVID-19）大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章2019-2031年全球注射抑菌水市場（依容器型態）
- 單劑量管瓶
- 多劑量管瓶
第6章全球注射抑菌水市場（依應用），2019-2031
- 藥品製造
- 醫療用途
- 診斷用途
- 其他
第 7 章 全球注射抑菌水市場，依最終用戶分類，2019-2031 年
- 醫院/診所
- 診斷實驗室
- 研究實驗室
- 其他
第8章2019-2031年全球注射抑菌水市場（按地區）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- 公司簡介
- Baxter International Inc.
- Fresenius Kabi AG
- Hospira, Inc.
- B. Braun Melsungen AG
- Eagle Pharmaceuticals, Inc.
- Sagent Pharmaceuticals, Inc.
- Baxter Healthcare Corporation
- MediPharma
- AstraZeneca
- Hikma Pharmaceuticals PLC
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Sandoz（a Novartis division）
- Merck &Co., Inc.
- GlaxoSmithKline PLC
- Cipla Limited
- Sun Pharmaceutical Industries Ltd.
- Roche Holding AG
- Alvogen
- Zydus Cadila
第10章分析師建議
第11章 參考文獻與調查方法
- 參考
- 調查方法
Global bacteriostatic water for injection market is estimated to be valued at USD 1.22 Billion in 2024 and is expected to reach USD 2.09 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1.22 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.00% | 2031 Value Projection: | US$ 2.09 Bn |
Bacteriostatic water for injection refers to sterile water that contains a suitable concentration of preservative to inhibit the growth of micro-organisms inoculated during its preparation or intended use. Bacteriostatic water is used in the reconstitution of powdered medications and other preparations to eliminate the risk of microbial contamination during injection or infusion. It is used in hospitals and clinics for reconstituting medications such as antibiotics, antifungal drugs and other injectable drugs. Growing prevalence of chronic and infectious diseases worldwide along with rising healthcare expenditures can boost demand for bacteriostatic water for injection over the forecast period.
Market Dynamics:
Increasing prevalence of chronic diseases such as cancer and cardiovascular disorders can boost demand for various therapeutic injectable drugs, and this is expected to drive the global bacteriostatic water for injection market growth during the forecast period. Rising healthcare expenditures along with improving access to healthcare facilities especially in developing countries can drive the market growth. However, availability of substitute products such as normal saline can hamper the market growth. Meanwhile, ongoing research towards development of more effective preservatives and formulations compatible with wider range of injectable drugs can offer lucrative opportunities for manufacturers in the near future.
Key features of the study:
This report provides in-depth analysis of the global bacteriostatic water for injection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
Key companies covered as a part of this study include B. Braun Medical Inc, HOSPIRA, Medline, Baxter, ICU Medical and Hyperdrug
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global bacteriostatic water for injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacteriostatic water for injection market
Detailed Segmentation-
- Container Type Insights (Revenue, USD Bn, 2019 - 2031)
- Single-Dose Vials
- Multi-Dose Vials
- Application Insights (Revenue, USD Bn, 2019 - 2031)
- Pharmaceutical Manufacturing
- Medical Use
- Diagnostic Applications
- Others
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital & Clinics
- Diagnostic Labs
- Research Labs
- Others
- Regional Insights (Revenue, USD Bn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Baxter International Inc.
- Fresenius Kabi AG
- Hospira, Inc.
- Braun Melsungen AG
- Eagle Pharmaceuticals, Inc.
- Sagent Pharmaceuticals, Inc.
- Baxter Healthcare Corporation
- MediPharma
- AstraZeneca
- Hikma Pharmaceuticals PLC
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Sandoz (a Novartis division)
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Cipla Limited
- Sun Pharmaceutical Industries Ltd.
- Roche Holding AG
- Alvogen
- Zydus Cadila
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Container Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Bacteriostatic Water for Injection Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Bacteriostatic Water for Injection Market, By Container Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Single-Dose Vials
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Multi-Dose Vials
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Bacteriostatic Water for Injection Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pharmaceutical Manufacturing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Medical Use
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diagnostic Applications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Bacteriostatic Water for Injection Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diagnostic Labs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research Labs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Bacteriostatic Water for Injection Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Baxter International Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hospira, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- B. Braun Melsungen AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eagle Pharmaceuticals, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sagent Pharmaceuticals, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Baxter Healthcare Corporation
- MediPharma
- AstraZeneca
- Hikma Pharmaceuticals PLC
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Sandoz (a Novartis division)
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Cipla Limited
- Sun Pharmaceutical Industries Ltd.
- Roche Holding AG
- Alvogen
- Zydus Cadila
- Baxter International Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
